Imipenem cilastatin labels and packages: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Labels and Packages== {| |- |[[|thumb|400px|left]] |- |} {| |- |[[|thumb|400px|left]] |- |} {| |- |[[|thumb|400px|left]] |- |} ...")
 
mNo edit summary
 
(2 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{imipenem cilastatin}}
{{imipenem cilastatin}}
{{CMG}}
{{CMG}}; {{AE}} {{SS}}


==Labels and Packages==
==Labels and Packages==
Line 7: Line 7:
{|
{|
|-
|-
|[[|thumb|400px|left]]
|[[File:Imipenem Cilastatin 8.jpg|thumb|400px|left]]
|-
|-
|}
|}
Line 13: Line 13:
{|
{|
|-
|-
|[[|thumb|400px|left]]
|[[File:Imipenem Cilastatin 9.jpg|thumb|400px|left]]
|-
|-
|}
|}
Line 19: Line 19:
{|
{|
|-
|-
|[[|thumb|400px|left]]
|[[File:Imipenem Cilastatin 10.jpg|thumb|400px|left]]
|-
|-
|}
|}
Line 25: Line 25:
{|
{|
|-
|-
|[[|thumb|400px|left]]
|[[File:Imipenem Cilastatin 11.jpg|thumb|400px|left]]
|-
|-
|}<ref>{{Cite web | last = | first = |title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | publisher =|date = | accessdate = }}</ref>
|}
 
==References==
{{Reflist}}


{{FDA}}
{{FDA}}

Latest revision as of 22:36, 5 January 2014

Imipenem Cilastatin
PRIMAXIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
Compatibility, Reconstitution, and Stability
Directions For Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Labels and Packages

Adapted from the FDA Package Insert.

Retrieved from "https://www.wikidoc.org/index.php?title=Imipenem_cilastatin_labels_and_packages&oldid=925109"